About Metatissue
Metatissue is a company based in Ilhavo (Portugal) founded in 2018 by Joao F Mano and Catarina Custodio. Metatissue offers products and services including Hydrogels and hPLMA Unit. Metatissue operates in a competitive market with competitors including Multus, Nu-Tek Biosciences, Kohjin Bio, Sarvoshadhi Bio and metabolIQ, among others.
- Headquarter Ilhavo, Portugal
- Founders Joao F Mano, Catarina Custodio
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website metatissue.com
- Social LinkedIn X Instagram
- Latest Funding Round$79.77K (USD), Grant
Jun 2022
- Investors
Products & Services of Metatissue
Metatissue offers a comprehensive portfolio of products and services, including Hydrogels and hPLMA Unit.
Human protein-based gels for 3D cell culture and tissue regeneration.
Lyophilized derivative for customizable hydrogels in research applications.
Funding Insights of Metatissue
- Total Rounds 3
- Last Round Grant — $79,770
- First Round $980,894
(Jan 2021)
- Investors Count 1
All 3 funding rounds of Metatissue with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $79,770 | Grant | – | – | |
| Sep 2021 | $658,586 | Grant | – | – | |
| Jan 2021 | $980,894 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Metatissue
Metatissue has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Metatissue
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Metatissue
2 people are tracked at Metatissue (2 in leadership).
| Name | Role | Group |
|---|---|---|
Joao F Mano | Co-Founder | Leadership |
Catarina Custodio | Co-Founder & CEO | Leadership |
Complete people profiles for Metatissue
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Metatissue
3 dated milestones of Metatissue across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Metatissue is founded.
- Funding First funding round of $981K.
- Funding Latest funding round, Grant, of $80K.
Competitors of Metatissue
Metatissue operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multus, Nu-Tek Biosciences, Kohjin Bio, Sarvoshadhi Bio and metabolIQ, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| multus.bio | 2019 | London, United Kingdom | $9.3M | 8 | Provider of lab-grown meat alternatives | |
| nu-tekbiosciences.com | 2008 | Minnetonka, United States | – | – | Develops innovative animal-free peptones and cell culture media for pharmaceutical use. | |
| kohjin-bio.jp | 1981 | Sakado, Japan | – | – | Tissue culture media provided for regenerative medicine and immunotherapy research. | |
| sarvoshadhi.com | 2017 | Kolhapur, India | – | – | Customized cell culture media for biotechnology are developed. | |
| metaboliq.ca | 2022 | Canada | – | – | Developer of cell culture medium for pharmaceutical screening and personalized medicine | |
| onkologic.com | 2021 | Farmington, United States | $305,000 | – | NK cell culture media is developed for cancer cell therapies. | |
| alt-biotech.com | 2023 | Evry Courcouronnes, France | – | – | Delivers comprehensive cell-culture solutions for producing non-therapeutic recombinant proteins. | |
| cet.bio | 2000 | Coralville, United States | $45,000 | – | Cell lines and stem cell products are supplied to researchers. |
Detailed competitors of Metatissue
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Metatissue
10 companies that operate in the same segment as Metatissue (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Metatissue
Metatissue was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Metatissue is headquartered in Ilhavo, Portugal. It is registered at Ilhavo, Aveiro, Portugal.
Catarina Custodio is the current CEO of Metatissue. They have also founded this company.
Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications. The companys products chemically modified human-derived proteins to prepare hydrogels, sponges and bioinks that mimic the human environment, enabling researchers to develop in vitro models and reduce the need for animal testing.
Metatissue's top competitors include Multus, Onkologic and Cellular Engineering Technologies.
Metatissue offers Hydrogels and hPLMA Unit.
Metatissue has 1 investor. Key investors include European Union.